Your browser doesn't support javascript.
loading
Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer.
Nakajima, Hiromichi; Harano, Kenichi; Nakai, Tokiko; Kusuhara, Shota; Nakao, Takehiro; Funasaka, Chikako; Kondoh, Chihiro; Matsubara, Nobuaki; Naito, Yoichi; Hosono, Ako; Mitsunaga, Shuichi; Ishii, Genichiro; Mukohara, Toru.
Afiliação
  • Nakajima H; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Courses of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Harano K; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: kharano@east.ncc.go.jp.
  • Nakai T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kusuhara S; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nakao T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Funasaka C; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kondoh C; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Matsubara N; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Naito Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hosono A; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Pediatric Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Mitsunaga S; Courses of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Ishii G; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
  • Mukohara T; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Breast ; 61: 136-144, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34999427
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados / Maitansina Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados / Maitansina Idioma: En Ano de publicação: 2022 Tipo de documento: Article